Navigation Links
Pharma Market Research Evolving to Fit Changing Healthcare Industry Dynamics
Date:7/22/2011

CHAPEL HILL, N.C., July 22, 2011 /PRNewswire/ -- Leading pharmaceutical and biotech organizations understand the value of using Market Research to inform their strategic planning and operational tactics across numerous functions.

As companies evolve, Market Research must also adapt and develop new capabilities in order to support intelligent planning and innovative business decision making.

Two areas where Market Research leaders anticipate providing more support in the future are new product development and strategic planning, according to research from Best Practices, LLC.  

"The Future of Market Research: Challenges and Changes in a Core Pharmaceutical Function" provides executives and managers working in Market Research and business intelligence areas with forward-looking insights around critical Market Research topics.

Sample key findings from this report include:

  • Currently, New Product Development and Strategic Planning responsibilities are split between Market Research and other organizations. A strong refocusing on development and planning suggests Market Research's vital role in strategic decision support.

  • More than two-thirds of respondents believe Market Research will balance strategic and tactical work in three to five years. Few believe tactical Market Research will be the main focus of the function in three to five years.

Data for this study were collected utilizing primary research via an online survey that drew 42 executives and analysts from 35 leading companies in the pharmaceutical, biotechnology and medical device sectors.  

To download a complimentary white paper of this report, go to: http://www3.best-in-class.com/rr1097.htm.

The full 46-page report contains more than 120 benchmark metrics and 30 best practices, providing pharmaceutical Market Research executives a roadmap for defining how the Market Research function can continue to provide value through staffing, vendors, development, metrics and practices in the next three to five years.

Key topics of this primary research include:

  • Market Research Roles & Responsibilities
  • Use of Outside Resources
  • Market Research Talent Selection & Development
  • Metrics & Performance
  • Best Practice Insights

For more information on this study and other recent primary research studies, contact Cameron Tew, Executive Director of Research, at 919.403.9246 or at ctew@best-in-class.com.  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
2. Merz Pharmaceuticals Commends The Benign Essential Blepharospasm Research Foundation On 30 Years Of Community Support
3. Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
4. Cal/OSHA Fines Prominent Pharmaceutical Firm $371,000 for Safety Violations Leading to Worker Fatality
5. Mail-Order Pharmacy for New Statin Prescriptions Achieve Better Cholesterol Control in First 3-15 Months of Therapy
6. 2011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent
7. Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]
8. Assured Pharmacy Upgrades to OTC Pink Current Information
9. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
10. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
11. Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):